Crypto Co restates fiscal 2024 financials over $1.3M derivative liability omission
Crypto Co's Audit Committee concluded on June 24, 2026 that the company's audited financial statements for the fiscal year ended December 31, 2024, should no…
$1.3M
By date
Newsworthy SEC filings briefed on Jun 24, 2026.
15 stories
Crypto Co's Audit Committee concluded on June 24, 2026 that the company's audited financial statements for the fiscal year ended December 31, 2024, should no…
Mobiquity Technologies and Stephano Slack LLC mutually agreed on June 18, 2026 to terminate Slack's services as the company's independent registered public…
Tax Credits International Inc, a Puerto Rico corporation, disclosed beneficial ownership of 9,370,600 shares, or 46.9% of the class, in Made in USA Inc. The…
Lawrence M.
Salva Francisco D.
Investor First Fund, a Texas limited liability company in REITs and finance, filed a Form D for a $50 million equity offering under Rule 506(c), permitting…
Ollin Biosciences, a Delaware biotechnology corporation, has sold $156,249,990 of a $330,000,000 private equity offering under Regulation D Rule 506(b).
Nomos AI, Inc., a Delaware corporation in other technology, sold $119,999,209 in equity securities to 19 investors under Regulation D Rule 506(b), with the…
SRX Global was notified by NYSE American on March 23, 2026 that it failed to comply with continued listing standards after its stock closed below $0.10 on…
Definitive Healthcare Corp. received notice from Nasdaq on June 18, 2026, that its common stock failed to meet the minimum bid price requirement of $1.00 per…
Bubblr Inc. dismissed BCRG Group as its independent registered public accounting firm on June 23, 2026, and simultaneously appointed Simon & Edward LLP as its…
Hoyne Bancorp's Audit Committee dismissed Wipfli LLP as independent auditor effective June 22, 2026, and engaged Plante & Moran, PLLC as the new auditor for…
On June 23, 2026, the Nasdaq Hearings Panel denied Aditxt's request to continue listing and determined to delist the company's common stock, with trading…
Passage Bio, Inc. has agreed to merge with Remix Therapeutics, Inc., with Remix's shareholders receiving shares of Passage common stock based on a formula…
Eli Lilly and Company completed its acquisition of Centessa Pharmaceuticals plc on June 24, 2026, pursuant to a court-sanctioned scheme of arrangement under…